Top-News
  • Depot
  • Watchlist
  • Glocke
  • Handeln

    • Purple Biotech Ltd. ADR News

    0,4699 $ +1,93% +0,0089 $
    In : 0,4411 € | 15:30:00 Uhr Nasdaq aktualisieren | Orderbuch | Mehr Kurse »
    WKN: A2QLTP
    ISIN: US74638P1093
    US-Symbol: PPBT
    Typ: Aktie

    Purple Biotech Ltd. ADR News

    04.06.21 - PR Newswire
    Thinking about buying stock in Senseonics, Xeris Pharmaceuticals, Purple Biotech, Targa Resources, or BlackBerry?
    Thinking about buying stock in Senseonics, Xeris Pharmaceuticals, Purple Biotech, Targa Resources, or BlackBerry? PR Newswire
    08.02.21 - PR Newswire
    Thinking about buying stock in Ocugen, Westport Fuel Systems, Purple Biotech, TherapeuticsMD, or Veru?
    Thinking about buying stock in Ocugen, Westport Fuel Systems, Purple Biotech, TherapeuticsMD, or Veru? PR Newswire
    07.07.20 - PR Newswire
    Thinking about buying stock in Seanergy Maritime Holdings, Kitov Pharma, Gevo Inc, Vivint Solar, or Hepion Pharmaceuticals?
    Thinking about buying stock in Seanergy Maritime Holdings, Kitov Pharma, Gevo Inc, Vivint Solar, or Hepion Pharmaceuticals? PR Newswire
    01.07.20 - PR Newswire
    Thinking about buying stock in T2 Biosystems, Ameresco Inc, Xeris Pharmaceuticals, Blink Charging, or Kitov Pharma?
    Thinking about buying stock in T2 Biosystems, Ameresco Inc, Xeris Pharmaceuticals, Blink Charging, or Kitov Pharma? PR Newswire
    29.06.20 - PR Newswire
    Thinking about buying stock in CleanSpark Inc, Workhorse Group, Kitov Pharma, Can Fite Biopharma, or TOP Ships?
    Thinking about buying stock in CleanSpark Inc, Workhorse Group, Kitov Pharma, Can Fite Biopharma, or TOP Ships? PR Newswire
    26.06.20 - PR Newswire
    Thinking about buying stock in Vaxart Inc, Zomedica Pharmaceuticals, Kitov Pharma, Gap Inc, or Heat Biologics?
    Thinking about buying stock in Vaxart Inc, Zomedica Pharmaceuticals, Kitov Pharma, Gap Inc, or Heat Biologics? PR Newswire
    24.06.20 - PR Newswire
    Thinking about buying stock in SINTX Technologies, Kitov Pharma, Titan Pharmaceuticals, T-Mobile, or Nio Inc?
    Thinking about buying stock in SINTX Technologies, Kitov Pharma, Titan Pharmaceuticals, T-Mobile, or Nio Inc? PR Newswire
    08.05.20 - PR Newswire
    Thinking about buying stock in Seanergy Maritime, Kitov Pharma, TOP Ships, Exela Technologies, or Roku?
    Thinking about buying stock in Seanergy Maritime, Kitov Pharma, TOP Ships, Exela Technologies, or Roku? PR Newswire
    16.01.19 - PR Newswire
    Thinking about buying stock in Aurora Cannabis Inc, Goodyear Tire & Rubber, Kitov Pharma, PG&E Corp or VirnetX?
    Thinking about buying stock in Aurora Cannabis Inc, Goodyear Tire & Rubber, Kitov Pharma, PG&E Corp or VirnetX? PR Newswire
    13.04.18 - PR Newswire
    TyrNovo to Present at 2018 Annual Meeting of the American Association for Cancer Research
    TyrNovo to Present at 2018 Annual Meeting of the American Association for Cancer Research Treatment with TyrNovo's NT219 in combination with targeted cancer drugs, as well as ...
    08.03.18 - PR Newswire
    TyrNovo to Present at BIO-Europe Spring® 2018 Conference
    TyrNovo to Present at BIO-​Europe Spring® 2018 Conference Treatment with TyrNovo's NT219 in combination with targeted cancer drugs, as well as chemotherapy and immuno-...
    05.03.18 - PR Newswire
    Kitov Pharmaceuticals Publishes Annual Report for 2017 and Issues CEO Letter to Shareholders
    Kitov Pharmaceuticals Publishes Annual Report for 2017 and Issues CEO Letter to Shareholders PR Newswire
    14.12.17 - PR Newswire
    Kitov Announces Consensi™ as Brand Name for KIT-302
    Kitov Announces Consensi™ as Brand Name for KIT-302 PR Newswire
    01.11.17 - PR Newswire
    Kitov Pharmaceuticals Announces Receipt of FDA's Favorable Response to NT219's pre-IND Meeting Package
    Kitov Pharmaceuticals Announces Receipt of FDA's Favorable Response to NT219's pre-IND Meeting Package TyrNovo to Initiate Clinical Development on Advanced Pancreatic ...
    26.10.17 - PR Newswire
    Kitov Pharmaceuticals Announces Phase III/IV Clinical Trial for KIT-302 Successfully Meets Primary Endpoint, and also Demonstrates Drug Candidate Improves Renal Function
    Kitov Pharmaceuticals Announces Phase III/IV Clinical Trial for KIT-302 Successfully Meets Primary Endpoint, and also Demonstrates Drug Candidate Improves Renal Function PR ...
    06.10.17 - PR Newswire
    Kitov Boosts Ownership in TyrNovo and Oncology Platform Through Exchange of Shares for Stock
    Kitov Boosts Ownership in TyrNovo and Oncology Platform Through Exchange of Shares for Stock - Kitov acquires an additional 27% ownership stake in TyrNovo and NT219, its ...
    02.10.17 - PR Newswire
    Kitov Announces Filing by FDA of New Drug Application for KIT-302
    Kitov Announces Filing by FDA of New Drug Application for KIT-302 PR Newswire
    16.08.17 - PR Newswire
    Kitov Pharmaceuticals Provides Corporate Update and Reports First Half 2017 Financial Results
    Kitov Pharmaceuticals Provides Corporate Update and Reports First Half 2017 Financial Results PR Newswire
    31.07.17 - PR Newswire
    Kitov Submits New Drug Application to FDA for KIT-302
    Kitov Submits New Drug Application to FDA for KIT-302 PR Newswire
    18.07.17 - PR Newswire
    Kitov Announces Results of Study Demonstrating NT-219 Enhanced Efficacy of Keytruda® in Immune-Oncology Preclinical Model
    Kitov Announces Results of Study Demonstrating NT-219 Enhanced Efficacy of Keytruda® in Immune-​Oncology Preclinical Model PR Newswire

    Newssuche

    Videos

    newspaper
    18.04.24
    Technical Trading: Gold mit weiterem Potenzial
    Gold Long Typ: Turbo Open End WKN: UH4MU6 Hebel: 4,67 Laufzeit: OpenEnd Einstieg: Market ... Mehr »